Impact of robotic and open surgery on patient wound complications in gastric cancer surgery: A meta-analysis.

Journal: International wound journal
PMID:

Abstract

This meta-analysis is intended to evaluate the effect of both robotic and open-cut operations on postoperative complications of stomach carcinoma. From the earliest date until June 2023, a full and systemic search has been carried out on four main databases with keywords extracted from 'Robot', 'Gastr' and 'Opene'. The ROBINS-I instrument has been applied to evaluate the risk of bias in nonrandomized controlled trials. In these 11 trials, a total of 16 095 patients had received surgical treatment for stomach cancer and all 11 trials were nonrandomized, controlled trials. Abdominal abscesses were reported in 5 trials, wound infections in 8 trials, haemorrhage in 7 trials, wound dehiscence in 2 trials and total postoperative complications in 4 trials. Meta-analyses revealed no statistically significantly different rates of postoperative abdominal abscesses among patients who had received robotic operations than in those who had received open surgical procedures (OR, 0.91; 95% CI, 0.25, 3.36; p = 0.89). The incidence of bleeding after surgery was not significantly different from that in both groups (OR, 1.37; 95% CI, 0.69, 2.75; p = 0.37). Similarly, there was no significant difference between the two groups (OR, 0.78; 95% CI, 0.52, 1.18; p = 0.24). No significant difference was found between the two groups (OR, 1. 28; 95% CI, 0.75, 2.21; p = 0.36). No significant difference was found between the two groups of patients who had received the robotic operation and those who had received the surgery after the operation (OR, 1.14; 95% CI, 0.78, 1.66; p = 0.49). Generally speaking, this meta-analysis suggests that the use of robotics does not result in a reduction in certain postsurgical complications, including wound infections and abdominal abscesses. Thus, the use of a microinvasive robot for stomach carcinoma operation might not be better than that performed on the surgical site after the operation. This is a valuable guide for the surgeon to select the operative method.

Authors

  • Lu Ye
    Department of Medical Oncology of Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Qian Yang
    Center for Advanced Scientific Instrumentation, University of Wyoming, Laramie, WY, United States.
  • Yuyu Xue
    School of Preclinical Medicine, Chengdu University, Chengdu, China.
  • Rong Jia
    School of Electrical Engineering, Xi'an University of Technology, Xi'an, Shaanxi, China.
  • Li Yang
    Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Lili Zhong
    Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, The Second Hospital of Jilin University, Changchun, Jilin, 130041, People's Republic of China. lilizhong1819@163.com.
  • Liqun Zou
    Department of Head and Neck Cancer, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Yao Xie
    Georgia Institute of Technology.